Madrigal Pharmaceuticals, Inc. (MDGL) KPIs & Operating Metrics

Name: MDGL (Madrigal Pharmaceuticals, Inc.) KPIs and Operating Metrics
Creator: Signals.AI

Madrigal Pharmaceuticals, Inc. (MDGL) key performance indicators and operating metrics (2 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.

KPIs — source: SEC EDGAR, earnings calls, investor decks
Metric	Latest Value	Period
Patients actively on ResDifera therapy	42.25K	FY2026-Q1
ResDifera net sales	311.3M	FY2026-Q1

Back to MDGL overview · MDGL earnings · MDGL holders

Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.